DK79985D0 - Kloning af dna for protozoelle antigener og dets anvendelse - Google Patents

Kloning af dna for protozoelle antigener og dets anvendelse

Info

Publication number
DK79985D0
DK79985D0 DK79985A DK79985A DK79985D0 DK 79985 D0 DK79985 D0 DK 79985D0 DK 79985 A DK79985 A DK 79985A DK 79985 A DK79985 A DK 79985A DK 79985 D0 DK79985 D0 DK 79985D0
Authority
DK
Denmark
Prior art keywords
antigenes
protocol
cloning dna
cloning
dna
Prior art date
Application number
DK79985A
Other languages
English (en)
Other versions
DK79985A (da
Inventor
Anthony Arthur Holder
Michael James Lockyer
Jasbir Singh Sandhu
Valentina Riveros-Moreno
Karel Gerrit Odink
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848404692A external-priority patent/GB8404692D0/en
Priority claimed from GB848424340A external-priority patent/GB8424340D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK79985D0 publication Critical patent/DK79985D0/da
Publication of DK79985A publication Critical patent/DK79985A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK79985A 1984-02-22 1985-02-21 Kloning af dna for protozoelle antigener og dets anvendelse DK79985A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848404692A GB8404692D0 (en) 1984-02-22 1984-02-22 Cloning of dna for protozoal antigens
GB848424340A GB8424340D0 (en) 1984-09-26 1984-09-26 Cloning of dna

Publications (2)

Publication Number Publication Date
DK79985D0 true DK79985D0 (da) 1985-02-21
DK79985A DK79985A (da) 1985-08-23

Family

ID=26287348

Family Applications (1)

Application Number Title Priority Date Filing Date
DK79985A DK79985A (da) 1984-02-22 1985-02-21 Kloning af dna for protozoelle antigener og dets anvendelse

Country Status (14)

Country Link
US (1) US5597708A (da)
EP (1) EP0154454B1 (da)
JP (2) JP2584733B2 (da)
AT (1) ATE64957T1 (da)
AU (1) AU592749B2 (da)
CA (1) CA1340103C (da)
DE (1) DE3583347D1 (da)
DK (1) DK79985A (da)
GB (1) GB2154592A (da)
HU (1) HU200794B (da)
IL (1) IL74409A (da)
NZ (1) NZ211191A (da)
PH (1) PH25993A (da)
ZW (1) ZW2485A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584300D1 (de) * 1984-02-21 1991-11-14 Nat Res Dev Herstellung von malaria-impfstoffen.
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
IL78476A0 (en) * 1985-04-11 1986-08-31 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
US4978621A (en) * 1985-09-03 1990-12-18 Scripps Clinic And Research Foundation Merozoite surface antigens
IL81026A0 (en) * 1985-12-24 1987-03-31 Inst Medical W & E Hall Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
EP0252588A3 (en) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB8706599D0 (en) * 1987-03-19 1987-04-23 Hoffmann La Roche Plasmodium falciparum merozoite antigen peptides
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
DE3831351A1 (de) * 1987-12-30 1989-07-13 Behringwerke Ag Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
US5756101A (en) * 1991-07-01 1998-05-26 Pasteur Merieux Serums Et Vaccins Malaria recombinant poxvirus
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744723A1 (fr) * 1996-02-14 1997-08-14 Pasteur Institut Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19640817A1 (de) * 1996-10-02 1998-05-14 Hermann Prof Dr Bujard Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1
UY27304A1 (es) 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
US20040082048A1 (en) * 2002-10-15 2004-04-29 Viswanath Nittala Venkata Narasimha Genes and protein sequences useful as drug targets for therapeutic action against protozoa
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AU2004268941A1 (en) * 2003-08-22 2005-03-10 Avanir Pharmaceuticals Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
US20060229314A1 (en) 2005-03-24 2006-10-12 Jagadish Sircar Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7931908B2 (en) * 2007-02-23 2011-04-26 Philadelphia Health Education Corporation Chimeric MSP-based malaria vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules

Also Published As

Publication number Publication date
DK79985A (da) 1985-08-23
GB8504429D0 (en) 1985-03-27
ZW2485A1 (en) 1986-09-24
GB2154592A (en) 1985-09-11
EP0154454B1 (en) 1991-07-03
NZ211191A (en) 1988-01-08
IL74409A (en) 1994-08-26
AU3904685A (en) 1985-09-05
JP2584733B2 (ja) 1997-02-26
ATE64957T1 (de) 1991-07-15
DE3583347D1 (de) 1991-08-08
CA1340103C (en) 1998-10-27
AU592749B2 (en) 1990-01-25
JPH06189772A (ja) 1994-07-12
JPS6119490A (ja) 1986-01-28
HU200794B (en) 1990-08-28
JP2893626B2 (ja) 1999-05-24
HUT37460A (en) 1985-12-28
PH25993A (en) 1992-01-13
US5597708A (en) 1997-01-28
EP0154454A1 (en) 1985-09-11
IL74409A0 (en) 1985-05-31

Similar Documents

Publication Publication Date Title
DK79985A (da) Kloning af dna for protozoelle antigener og dets anvendelse
DE68910713D1 (de) Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.
ATE114169T1 (de) Morphogenetisches knochenprotein.
NO863560L (no) Dentalartikler og silanol-grunningsopploesning for bruk paa slike artikler.
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
FR2563434B1 (fr) Vaccin contre la rage et procede pour sa preparation
DE3877428D1 (de) Kondensationsprodukte von silanol, deren herstellung und verwendungen.
DE3582203D1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparum-antigenen.
FI885237A7 (fi) Menetelmä yhdistelmä-E. colissa ilmennetyn P. falciparum-CS-proteiinir okotteen eristämiseksi ja puhdistamiseksi
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
DE3873945D1 (de) Verwendung von polyglutaminsaeure in nahrungsmitteln.
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
FI883005A7 (fi) Promoottoreita vieras-DNA:n ilmaisemiseksi metylotrofisissa bakteereissa, niiden talteenotto ja niiden käyttö.
DE3584300D1 (de) Herstellung von malaria-impfstoffen.
DE69536025D1 (de) Methode zur direkten Klonierung von Nukleasegenen in E.coli
DE3881123D1 (de) Klonieren von fuer einen antibakteriellen polypeptidvorlaeufer kodierender dna und expression des vorlaeufers.
NO874490D0 (no) Kloning og anvendelse av transaminasegenet ilv-e.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
DK587588D0 (da) Polypeptid, dets anvendelse og fremstilling
DE3880110D1 (de) Herstellung von m-aminophenol.
ATE97442T1 (de) Isolierung, reinigung, charakterisierung, klonierung und sequenzierung von n-alphaacetyltransferase.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment